Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 21.91% is in line with its 5-year average of 21.45%, around the middle of its 5-year range (17.89%–25.29%).
1.85% above its 12-month average of 21.51%.
Reported quarterly profit margin; no daily interpolation.
NET PROFIT MARGIN
21.91%
NET PROFIT MARGIN AVG TTM
21.51%
NET PROFIT MARGIN AVG 3Y
21.38%
NET PROFIT MARGIN AVG 5Y
21.45%
NET PROFIT MARGIN AVG 10Y
19.33%
NET PROFIT MARGIN AVG 15Y
17.25%
NET PROFIT MARGIN AVG 20Y
15.55%
CURRENT VS TTM AVG
+1.85%
CURRENT VS 3Y AVG
+2.49%
CURRENT VS 5Y AVG
+2.15%
CURRENT VS 10Y AVG
+13.36%
CURRENT VS 15Y AVG
+26.98%
CURRENT VS 20Y AVG
+40.93%
SECTOR MEDIAN · HEALTHCARE
8.98%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+143.99%
vs the sector median at left
Mettler-Toledo International Inc.
Market Cap
$26.79B
Net Profit Margin
21.91%
TTM Avg
21.51%
3Y Avg
21.38%
5Y Avg
21.45%
Market Cap
$26.64B
Net Profit Margin
6.99%
TTM Avg
6.01%
3Y Avg
6.56%
5Y Avg
9.24%
Market Cap
$25.99B
Net Profit Margin
9.19%
TTM Avg
8.91%
3Y Avg
9.15%
5Y Avg
11.71%
Market Cap
$25.22B
Net Profit Margin
27.71%
TTM Avg
12.90%
3Y Avg
13.00%
5Y Avg
12.11%
Market Cap
$23.79B
Net Profit Margin
16.98%
TTM Avg
16.55%
3Y Avg
18.38%
5Y Avg
18.84%
Market Cap
$30.13B
Net Profit Margin
3.58%
TTM Avg
20.93%
3Y Avg
21.85%
5Y Avg
22.39%
Market Cap
$30.16B
Net Profit Margin
7.86%
TTM Avg
10.12%
3Y Avg
9.68%
5Y Avg
22.03%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mettler-Toledo International Inc. (MTD) | $26.79B | 21.91% | 21.51% | 21.38% | 21.45% |
| Labcorp Holdings Inc. (LH)vs › | $26.64B | 6.99% | 6.01% | 6.56% | 9.24% |
| Quest Diagnostics Incorporated (DGX)vs › | $25.99B | 9.19% | 8.91% | 9.15% | 11.71% |
| Incyte Corporation (INCY)vs › | $25.22B | 27.71% | 12.90% | 13.00% | 12.11% |
| BioNTech SE (BNTX)vs › | $24.78B | -62.98% | -31.89% | 3.77% | 12.08% |
| Medline Inc. (MDLN)vs › | $29.33B | 2.31% | 4.39% | 2.42% | 2.42% |
| West Pharmaceutical Services, Inc. (WST)vs › | $23.79B | 16.98% | 16.55% | 18.38% | 18.84% |
| Waters Corporation (WAT)vs › | $30.13B | 3.58% | 20.93% | 21.85% | 22.39% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $30.16B | 7.86% | 10.12% | 9.68% | 22.03% |
| Zoetis Inc. (ZTS)vs › | $30.86B | 27.49% | 27.55% | 27.17% | 26.57% |
Operating Margin
28.7%
Net Profit Margin
21.9%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 22.67% |
| 2026-03-31 | 17.89% |
| 2025-12-31 | 25.29% |
| 2025-09-30 | 21.12% |
| 2025-06-30 | 20.58% |
| 2025-03-31 | 18.51% |
| 2024-12-31 | 24.14% |
| 2024-09-30 | 22.16% |
| 2024-06-30 | 23.43% |
| 2024-03-31 | 19.17% |
| 2023-12-31 | 19.76% |
| 2023-09-30 | 21.39% |
| 2023-06-30 | 21.78% |
| 2023-03-31 | 20.29% |
| 2022-12-31 | 25.13% |
| 2022-09-30 | 22.38% |
| 2022-06-30 | 21.68% |
| 2022-03-31 | 19.38% |
| 2021-12-31 | 22.26% |
| 2021-09-30 | 21.40% |
| 2021-06-30 | 19.99% |
| 2021-03-31 | 18.61% |
| 2020-12-31 | 23.06% |
| 2020-09-30 | 20.04% |
| 2020-06-30 | 18.32% |
| 2020-03-31 | 15.11% |
| 2019-12-31 | 22.84% |
| 2019-09-30 | 17.16% |
| 2019-06-30 | 17.39% |
| 2019-03-31 | 16.46% |
| 2018-12-31 | 22.15% |
| 2018-09-30 | 17.24% |
| 2018-06-30 | 15.44% |
| 2018-03-31 | 14.12% |
| 2017-12-31 | 9.89% |
| 2017-09-30 | 15.02% |
| 2017-06-30 | 15.54% |
| 2017-03-31 | 15.55% |
| 2016-12-31 | 19.41% |
| 2016-09-30 | 15.58% |
| 2016-06-30 | 13.08% |
| 2016-03-31 | 12.17% |
| 2015-12-31 | 18.31% |
| 2015-09-30 | 14.71% |
| 2015-06-30 | 13.32% |
| 2015-03-31 | 11.77% |
| 2014-12-31 | 17.37% |
| 2014-09-30 | 13.51% |
| 2014-06-30 | 12.16% |
| 2014-03-31 | 10.54% |
| 2013-12-31 | 16.10% |
| 2013-09-30 | 12.56% |
| 2013-06-30 | 11.93% |
| 2013-03-31 | 10.02% |
| 2012-12-31 | 15.92% |
| 2012-09-30 | 12.48% |
| 2012-06-30 | 10.82% |
| 2012-03-31 | 9.77% |
| 2011-12-31 | 14.54% |
| 2011-09-30 | 11.34% |
| 2011-06-30 | 10.73% |
| 2011-03-31 | 9.39% |
| 2010-12-31 | 13.64% |
| 2010-09-30 | 12.66% |
| 2010-06-30 | 10.96% |
| 2010-03-31 | 9.09% |
| 2009-12-31 | 13.57% |
| 2009-09-30 | 9.54% |
| 2009-06-30 | 6.81% |
| 2009-03-31 | 9.06% |
| 2008-12-31 | 12.35% |
| 2008-09-30 | 10.36% |
| 2008-06-30 | 9.47% |
| 2008-03-31 | 8.72% |
| 2007-12-31 | 11.87% |
| 2007-09-30 | 9.89% |
| 2007-06-30 | 9.53% |
| 2007-03-31 | 7.85% |
| 2006-12-31 | 11.25% |
| 2006-09-30 | 11.84% |
| 2006-06-30 | 8.93% |
| 2006-03-31 | 6.85% |
| 2005-12-31 | 10.75% |
| 2005-09-30 | 7.01% |
| 2005-06-30 | 4.97% |
| 2005-03-31 | 6.16% |
| 2004-12-31 | 9.09% |
| 2004-09-30 | 7.20% |
| 2004-06-30 | 8.25% |
| 2004-03-31 | 5.84% |
| 2003-12-31 | 8.89% |
| 2003-09-30 | 7.54% |
| 2003-06-30 | 8.02% |
| 2003-03-31 | 4.43% |
| 2002-12-31 | 9.28% |
| 2002-09-30 | 7.48% |
